Skip to main content

Day: January 4, 2023

Sportradar to Participate in 25th Annual Needham Growth Conference

NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Sportradar Group AG (NASDAQ:SRAD) (“Sportradar”) announced today that Andrew Bimson, Sportradar’s President and Chief Operating Officer, North America, will participate in the 25th Annual Needham Growth Conference on Tuesday, January 10, 2023. Andrew Bimson will participate in a fireside chat at 8:45 a.m. EST. A link to the webcast and replay can be found at https://investors.sportradar.com About SportradarSportradar is the leading global sports technology company creating immersive experiences for sports fans and bettors. Established in 2001, the company is well-positioned at the intersection of the sports, media and betting industries, providing sports federations, news media, consumer platforms and sports betting operators with a range of solutions to help grow their business. Sportradar...

Continue reading

Eterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using advanced cell engineering technology to develop transformational new medicines, today announced the appointment of Matt Angel, Ph.D. as Chief Executive Officer (“CEO”) and President. Dr. Angel has served as Interim CEO and President of Eterna since May 2022 and will continue to serve on the Company’s Board of Directors. “The Board and I are delighted that Matt will serve as CEO and President in a permanent capacity, and we remain confident in his continued ability to lead Eterna as the company executes on its core strategy of advancing Eterna’s mRNA cell engineering platform,” said Charles Cherington, Chairman of the Board of Directors of Eterna. “While Interim CEO and President,...

Continue reading

180 Life Sciences Announces Publication of a Review on the Biological Basis of Dupuytren’s Disease

PALO ALTO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), today announced the publication of a review entitled ‘Dupuytren’s disease: a localized and accessible human fibrotic disorder’ in the journal Trends in Molecular Medicine. In the article, the authors at the University of Oxford, led by Professor Jagdeep Nanchahal, chairman of the medical advisory board of 180 Life Sciences, describe the biology of Dupuytren’s disease, to which they have made important contributions, recognized for example by the International Dupuytren Award in 2019, 2020 and 2021. The authors describe the genetics of this highly heritable disorder, the cellular mechanisms, the intercellular interactions and the key role of low-grade chronic inflammation in the pathogenesis of the disorder....

Continue reading

Allogene Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer, today announced that David Chang, M.D., Ph.D., President, Chief Executive Officer and Co-Founder, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023 at 3:45 p.m. Pacific Time. The event will be held in San Francisco at the Westin St. Francis. A live audio webcast of the presentation will be made available on the Company’s website at www.allogene.com under the Investors tab in the News and Events section. Following the live audio webcast, a replay will be available on the Company’s website for approximately 30 days. About Allogene TherapeuticsAllogene...

Continue reading

NeoGames Obtains WLA Responsible Gaming Certification

The World Lottery Association has certified that NeoGames’ iLottery technology and operations align with its responsible gaming standards LUXEMBOURG, Jan. 04, 2023 (GLOBE NEWSWIRE) — NeoGames S.A., (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery solutions, announced today that it has attained the World Lottery Association (“WLA”) Responsible Gaming certification. This global accreditation confirms that NeoGames has achieved full alignment with the WLA responsible gaming standards for Lottery suppliers. The WLA responsible gaming (“RG”) standards framework was created to minimize the impact of problem gaming. With the awareness of the ever-increasing role that responsible gaming plays in lottery ‎supplier operations, the WLA established an RG ‎standard adapted...

Continue reading

Genasys Inc. Secures Emergency Management and Evacuation Software Services Contract from Utah Counties

Zonehaven Used in Multiple California Counties to Communicate Flooding and Debris Flow Hazards SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions that help protect and keep people safe, today announced a Genasys Emergency Management (GEM) and Zonehaven software-as-a-service (SaaS) contract from three contiguous Utah counties. Genasys replaced competitors’ emergency notification systems. “Eastern Utah counties Daggett, Duchesne and Uintah join 39 counties in five Western states employing Genasys public safety software services under multi-year contracts to better protect their residents during disasters and critical events,” said Richard Danforth, Chief Executive Officer, Genasys Inc. “A national monument, a large dam...

Continue reading

Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference

NORTH BILLERICA, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced Mary Anne Heino, President and Chief Executive Officer, will present at the J.P. Morgan 2023 Healthcare Conference at 1:30 p.m. PST on Wednesday, January 11. To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation. About Lantheus With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving...

Continue reading

Non-Profit Health System Signs New Contract for Streamline Health® eValuator™

Chooses Automated Pre-Bill Coding Analysis to Improve Financial Performance Atlanta, GA, Jan. 04, 2023 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, announced today it has signed a contract with a 350-bed, Cerner-EHR health system based in Missouri. The organization will use eValuator’s automated pre-bill coding analysis technology to help improve revenue integrity and financial performance. Streamline Health is leading an industry movement to enable every hospital in the country to use pre-bill technology to improve financial performance. With eValuator, providers are identifying and addressing coding issues before they contribute to revenue leakage, denied claims and...

Continue reading

Redacted News Joins Rumble Exclusives

Clayton and Natali Morris join Russell Brand, Glenn Greenwald, and Dave Rubin by moving their full livestream exclusively to Rumble LONGBOAT KEY, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) — Rumble, the video-sharing platform (NASDAQ: RUM), announced today that Redacted News will distribute its full livestream exclusively on Rumble. Redacted News is hosted by former Fox News anchor Clayton Morris and his wife, Natali. The show focuses on providing in-depth analyses of legal, social, financial and political issues that are not covered by the mainstream media. To date, the Redacted News YouTube channel has garnered over 270 million views. “We live in an age when trust in corporate media is at an all-time low, and I’m thrilled to join a platform like Rumble that supports true journalism and freedom of speech,” said Clayton Morris. “We are...

Continue reading

Dyadic to Attend J.P. Morgan 41st Annual Healthcare Conference

Dyadic’s executive management to attend the J.P. Morgan 41st Annual Healthcare Conference and the 6th Annual BFC Global Healthcare BD and Investment Conference from January 8-12 in San Francisco, CA USA JUPITER, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial platforms to address the growing demand for global protein production and unmet clinical needs for effective and affordable biopharmaceutical products for human and animal health, today announces that its senior executive management will attend the J.P. Morgan 41st Annual Healthcare Conference in San Francisco, CA. Dyadic’s founder and CEO, Mark Emalfarb will be making a corporate presentation at 4:00 PM PT on January 8, 2023 at the 6th...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.